The Alliance for Clinical Trials in Oncology is a pivotal organization dedicated to combating cancer through innovative research and collaboration. Recognized as a member of the National Cancer Institute's (NCI) National Clinical Trials Network, the Alliance unites a diverse community of scientists and clinicians focused on enhancing prevention and treatment strategies for cancer patients. The organization offers robust support for clinical trials, including its groundbreaking ComboMATCH initiative, which investigates new drug combinations tailored to patients based on tumor biology.

This precision medicine platform aims to improve treatment efficacy for both adults and children with cancer. The Alliance also emphasizes member participation through regular meetings, updates, and educational resources. With a vision to reduce cancer's impact, the Alliance encourages involvement in clinical research, fostering an environment of shared knowledge and successful outcomes.

Whether through advocacy, research collaboration, or clinical trial participation, the Alliance is at the forefront of cancer research and patient care